Literature DB >> 11160108

Growth-phase-dependent expression of the cyclopeptide antibiotic microcin J25.

M J Chiuchiolo1, M A Delgado, R N Farías, R A Salomón.   

Abstract

Microcin J25 is a 2,107-Da, plasmid-encoded, cyclopeptide antibiotic produced by Escherichia coli. We have isolated lacZ fusions to mcjA (encoding the 58-amino-acid microcin precursor) and mcjB and mcjC (which are required for microcin maturation), and the regulation of these fusions was used to identify factors that control the expression of these genes. The mcjA gene was found to be dramatically induced as cells entered the stationary phase. Expression of mcjA could be induced by resuspending uninduced exponential-phase cells in spent supernatant obtained from an early-stationary-phase culture. Induction of mcjA expression was not dependent on high cell density, pH changes, anaerobiosis, or the buildup of some inducer. A starvation for carbon and inorganic phosphate induced mcjA expression, while under nitrogen limitation there was no induction at all. These results taken together suggest that stationary-phase induction of mcjA is triggered by nutrient depletion. The mcjB and mcjC genes were also regulated by the growth phase of the culture, but in contrast to mcjA, they showed substantial expression already during exponential growth. Induction of the microcin genes was demonstrated to be independent of RpoS, the cyclic AMP-Crp complex, OmpR, and H-NS. Instead, we found that the growth-phase-dependent expression of mcjA, mcjB, and mcjC may be explained by the concerted action of the positively acting transition state regulators ppGpp, Lrp, and integration host factor. Measurements of microcin J25 production by strains defective in these global regulators showed a good correlation with the reduced expression of the fusions in such mutant backgrounds.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160108      PMCID: PMC95062          DOI: 10.1128/JB.183.5.1755-1764.2001

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  39 in total

1.  Transcription regulation of the colicin K cka gene reveals induction of colicin synthesis by differential responses to environmental signals.

Authors:  I Kuhar; D Zgur-Bertok
Journal:  J Bacteriol       Date:  1999-12       Impact factor: 3.490

Review 2.  Histonelike proteins of bacteria.

Authors:  K Drlica; J Rouviere-Yaniv
Journal:  Microbiol Rev       Date:  1987-09

3.  Growth phase and ompR regulation of transcription of microcin B17 genes.

Authors:  C Hernández-Chico; J L San Millán; R Kolter; F Moreno
Journal:  J Bacteriol       Date:  1986-09       Impact factor: 3.490

4.  Positive and negative regulation of the Mu operator by Mu repressor and Escherichia coli integration host factor.

Authors:  H M Krause; N P Higgins
Journal:  J Biol Chem       Date:  1986-03-15       Impact factor: 5.157

5.  E. coli integration host factor binds to specific sites in DNA.

Authors:  N L Craig; H A Nash
Journal:  Cell       Date:  1984-12       Impact factor: 41.582

6.  Regulation of Mu transposition. I. Localization of the presumed recognition sites for HimD and Ner functions controlling bacteriophage Mu transcription.

Authors:  N Goosen; P van de Putte
Journal:  Gene       Date:  1984-10       Impact factor: 3.688

7.  Plasmid insertion mutagenesis and lac gene fusion with mini-mu bacteriophage transposons.

Authors:  B A Castilho; P Olfson; M J Casadaban
Journal:  J Bacteriol       Date:  1984-05       Impact factor: 3.490

Review 8.  Control of antibiotic biosynthesis.

Authors:  J F Martin; A L Demain
Journal:  Microbiol Rev       Date:  1980-06

9.  Growth phase-dependent variation in protein composition of the Escherichia coli nucleoid.

Authors:  T Ali Azam; A Iwata; A Nishimura; S Ueda; A Ishihama
Journal:  J Bacteriol       Date:  1999-10       Impact factor: 3.490

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  13 in total

1.  Stationary phase-like properties of the bacteriophage lambda Rex exclusion phenotype.

Authors:  R A Slavcev; S Hayes
Journal:  Mol Genet Genomics       Date:  2003-03-05       Impact factor: 3.291

2.  Escherichia coli RNA polymerase is the target of the cyclopeptide antibiotic microcin J25.

Authors:  M A Delgado; M R Rintoul; R N Farías; R A Salomón
Journal:  J Bacteriol       Date:  2001-08       Impact factor: 3.490

3.  Structure-activity analysis of microcinJ25: distinct parts of the threaded lasso molecule are responsible for interaction with bacterial RNA polymerase.

Authors:  Ekaterina Semenova; Yulia Yuzenkova; Jean Peduzzi; Sylvie Rebuffat; Konstantin Severinov
Journal:  J Bacteriol       Date:  2005-06       Impact factor: 3.490

4.  Protective action of ppGpp in microcin J25-sensitive strains.

Authors:  María Fernanda Pomares; Paula A Vincent; Ricardo N Farías; Raúl A Salomón
Journal:  J Bacteriol       Date:  2008-04-11       Impact factor: 3.490

Review 5.  The therapeutic applications of antimicrobial peptides (AMPs): a patent review.

Authors:  Hee-Kyoung Kang; Cheolmin Kim; Chang Ho Seo; Yoonkyung Park
Journal:  J Microbiol       Date:  2016-12-30       Impact factor: 3.422

6.  Isolation and Selection of Potential Probiotic Bacteria from the Pig Gastrointestinal Tract.

Authors:  Luca Lo Verso; Martin Lessard; Guylaine Talbot; Benoit Fernandez; Ismail Fliss
Journal:  Probiotics Antimicrob Proteins       Date:  2018-06       Impact factor: 4.609

7.  Sensitization of microcin J25-resistant strains by a membrane-permeabilizing peptide.

Authors:  María Fernanda Pomares; Mónica A Delgado; Natalia S Corbalán; Ricardo N Farías; Paula A Vincent
Journal:  Appl Environ Microbiol       Date:  2010-08-27       Impact factor: 4.792

8.  Identification and characterization of microcin S, a new antibacterial peptide produced by probiotic Escherichia coli G3/10.

Authors:  Anke Zschüttig; Kurt Zimmermann; Jochen Blom; Alexander Goesmann; Christoph Pöhlmann; Florian Gunzer
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

9.  Isolation and characterization of diverse antimicrobial lipopeptides produced by Citrobacter and Enterobacter.

Authors:  Santi M Mandal; Shalley Sharma; Anil Kumar Pinnaka; Annu Kumari; Suresh Korpole
Journal:  BMC Microbiol       Date:  2013-07-08       Impact factor: 3.605

10.  Antimicrobial Probiotics Reduce Salmonella enterica in Turkey Gastrointestinal Tracts.

Authors:  Brittany Forkus; Seth Ritter; Michail Vlysidis; Kathryn Geldart; Yiannis N Kaznessis
Journal:  Sci Rep       Date:  2017-01-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.